vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $47.3M, roughly 1.6× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -9.6%, a 10.7% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs -16.8%). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.

BIOX vs MAMA — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.6× larger
BIOX
$77.6M
$47.3M
MAMA
Growing faster (revenue YoY)
MAMA
MAMA
+66.8% gap
MAMA
50.0%
-16.8%
BIOX
Higher net margin
MAMA
MAMA
10.7% more per $
MAMA
1.1%
-9.6%
BIOX
Faster 2-yr revenue CAGR
MAMA
MAMA
Annualised
MAMA
33.0%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
BIOX
BIOX
MAMA
MAMA
Revenue
$77.6M
$47.3M
Net Profit
$-7.4M
$540.0K
Gross Margin
46.8%
23.6%
Operating Margin
9.3%
1.7%
Net Margin
-9.6%
1.1%
Revenue YoY
-16.8%
50.0%
Net Profit YoY
-20.2%
31.7%
EPS (diluted)
$-0.12
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
MAMA
MAMA
Q4 25
$47.3M
Q3 25
$77.6M
$35.2M
Q2 25
$35.3M
Q1 25
$60.6M
$33.6M
Q4 24
$98.8M
$31.5M
Q3 24
$93.3M
$28.4M
Q2 24
$29.8M
Q1 24
$84.0M
$26.7M
Net Profit
BIOX
BIOX
MAMA
MAMA
Q4 25
$540.0K
Q3 25
$-7.4M
$1.3M
Q2 25
$1.2M
Q1 25
$-1.6M
$1.6M
Q4 24
$605.2K
$410.0K
Q3 24
$-6.2M
$1.1M
Q2 24
$553.0K
Q1 24
$9.8M
$1.4M
Gross Margin
BIOX
BIOX
MAMA
MAMA
Q4 25
23.6%
Q3 25
46.8%
24.9%
Q2 25
26.1%
Q1 25
39.4%
27.0%
Q4 24
42.0%
22.6%
Q3 24
40.2%
24.2%
Q2 24
25.0%
Q1 24
50.8%
29.3%
Operating Margin
BIOX
BIOX
MAMA
MAMA
Q4 25
1.7%
Q3 25
9.3%
4.8%
Q2 25
4.5%
Q1 25
1.5%
5.7%
Q4 24
14.5%
1.8%
Q3 24
2.5%
5.7%
Q2 24
2.6%
Q1 24
15.7%
7.4%
Net Margin
BIOX
BIOX
MAMA
MAMA
Q4 25
1.1%
Q3 25
-9.6%
3.6%
Q2 25
3.5%
Q1 25
-2.6%
4.8%
Q4 24
0.6%
1.3%
Q3 24
-6.6%
4.0%
Q2 24
1.9%
Q1 24
11.6%
5.3%
EPS (diluted)
BIOX
BIOX
MAMA
MAMA
Q4 25
$0.01
Q3 25
$-0.12
$0.03
Q2 25
$0.03
Q1 25
$-0.02
$0.04
Q4 24
$0.00
$0.01
Q3 24
$-0.10
$0.03
Q2 24
$0.01
Q1 24
$0.14
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
MAMA
MAMA
Cash + ST InvestmentsLiquidity on hand
$15.5M
$18.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$49.6M
Total Assets
$734.9M
$84.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
MAMA
MAMA
Q4 25
$18.1M
Q3 25
$15.5M
$9.4M
Q2 25
$12.0M
Q1 25
$38.5M
$7.2M
Q4 24
$29.2M
$9.3M
Q3 24
$32.3M
$7.4M
Q2 24
$13.0M
Q1 24
$16.4M
$11.0M
Stockholders' Equity
BIOX
BIOX
MAMA
MAMA
Q4 25
$49.6M
Q3 25
$288.3M
$29.6M
Q2 25
$26.4M
Q1 25
$345.0M
$24.9M
Q4 24
$346.3M
$23.0M
Q3 24
$346.0M
$22.3M
Q2 24
$20.3M
Q1 24
$348.5M
$19.6M
Total Assets
BIOX
BIOX
MAMA
MAMA
Q4 25
$84.0M
Q3 25
$734.9M
$51.2M
Q2 25
$52.7M
Q1 25
$798.2M
$47.1M
Q4 24
$835.2M
$47.9M
Q3 24
$827.3M
$43.0M
Q2 24
$47.2M
Q1 24
$836.1M
$45.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
MAMA
MAMA
Operating Cash FlowLast quarter
$14.4M
$3.9M
Free Cash FlowOCF − Capex
$3.7M
FCF MarginFCF / Revenue
7.8%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
7.16×
TTM Free Cash FlowTrailing 4 quarters
$6.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
MAMA
MAMA
Q4 25
$3.9M
Q3 25
$14.4M
$-1.7M
Q2 25
$6.0M
Q1 25
$23.3M
$-857.0K
Q4 24
$-5.4M
$4.8M
Q3 24
$5.2M
$-2.4M
Q2 24
$3.6M
Q1 24
$-17.4M
$6.7M
Free Cash Flow
BIOX
BIOX
MAMA
MAMA
Q4 25
$3.7M
Q3 25
$-2.2M
Q2 25
$5.5M
Q1 25
$-930.0K
Q4 24
$2.5M
Q3 24
$-4.0M
Q2 24
$2.5M
Q1 24
$6.6M
FCF Margin
BIOX
BIOX
MAMA
MAMA
Q4 25
7.8%
Q3 25
-6.2%
Q2 25
15.5%
Q1 25
-2.8%
Q4 24
8.0%
Q3 24
-14.1%
Q2 24
8.4%
Q1 24
24.8%
Capex Intensity
BIOX
BIOX
MAMA
MAMA
Q4 25
0.4%
Q3 25
1.5%
Q2 25
1.5%
Q1 25
0.2%
Q4 24
7.2%
Q3 24
5.6%
Q2 24
3.8%
Q1 24
0.4%
Cash Conversion
BIOX
BIOX
MAMA
MAMA
Q4 25
7.16×
Q3 25
-1.31×
Q2 25
4.85×
Q1 25
-0.54×
Q4 24
-8.85×
11.71×
Q3 24
-2.10×
Q2 24
6.58×
Q1 24
-1.78×
4.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons